These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3454763)

  • 61. Monoclonal antibody production to a B16 melanoma associated antigen.
    Tomita Y; Montague PM; Hearing VJ
    Int J Cancer; 1985 Apr; 35(4):543-7. PubMed ID: 3886561
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparative immunohistochemical oestrogen receptor analysis in primary and metastatic uveal melanoma.
    Mäkitie T; Tarkkanen A; Kivelä T
    Graefes Arch Clin Exp Ophthalmol; 1998 Jun; 236(6):415-9. PubMed ID: 9646085
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Monoclonal anti-melanoma antibodies IKH-1 and IKH-2 which work on formalin-fixed, paraffin embedded tissues: characterization, clinical trials and comparative studies with HMB-45.
    Ishihara M; Hashimoto K; DiGregorio FM; Setoyama M; Richards J; Pietruk T; Zarbo RJ
    J Dermatol Sci; 1992 Jan; 3(1):13-25. PubMed ID: 1591223
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Characteristics and reactivities of a panel of monoclonal antibodies (McAbs) recognizing human colon cancer associated antigens].
    Liu MP
    Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):91-3. PubMed ID: 1618088
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O).
    Kelderman S; van der Kooij MK; van den Eertwegh AJ; Soetekouw PM; Jansen RL; van den Brom RR; Hospers GA; Haanen JB; Kapiteijn E; Blank CU
    Acta Oncol; 2013 Nov; 52(8):1786-8. PubMed ID: 23607756
    [No Abstract]   [Full Text] [Related]  

  • 66. Detection of a tumor-associated glycoprotein antigen in serum and urine of melanoma patients by murine monoclonal antibody (AD1-40F4) in enzyme immunoassay.
    Euhus DM; Gupta RK; Morton DL
    J Clin Lab Anal; 1989; 3(3):184-90. PubMed ID: 2754533
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Production of monoclonal antibodies against the B700 murine melanoma antigen and their antimetastatic properties.
    Gersten DM; Moody D; Vieira WD; Law LW; Hearing VJ
    Biochim Biophys Acta; 1992 Feb; 1138(2):109-14. PubMed ID: 1540656
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecular heterogeneity and shedding of a high-molecular-mass melanoma-associated antigen identified with monoclonal antibodies.
    Ng AK; Giacomini P; Kantor R; Ferrone S
    Clin Chem; 1982 Dec; 28(12):2347-50. PubMed ID: 6183026
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antigenic and cellular heterogeneity of primary uveal malignant melanomas.
    Donoso LA; Shields JA; Augsburger JJ; Whitman J; Arbizo V
    Arch Ophthalmol; 1986 Jan; 104(1):106-10. PubMed ID: 3942530
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tumor-associated antigen immune complexes. A potential marker of recurrent melanoma.
    Wong JH; Xu SH; Gupta RK; Morton DL
    Arch Surg; 1990 Feb; 125(2):187-91. PubMed ID: 2302059
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prospective evaluation of the use of antigen-specific immune complexes in predicting the development of recurrent melanoma.
    Wong JH; Xu SH; Skinner KA; Foshag LJ; Morton DL
    Arch Surg; 1991 Dec; 126(12):1450-4. PubMed ID: 1842173
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Distribution and organelle specificity of melanoma-associated antigens identified by Mo 465.12 in human malignant melanoma.
    Maeda K; Jimbow K; Akutsu Y; Imai K
    Cancer; 1985 Feb; 55(4):721-7. PubMed ID: 3967168
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The need for continuous immunosuppression with cyclosporin A to maintain an experimental model of uveal melanoma.
    Ordoñez JL; Saornil MA; Domingo E; Blanco G; Diebold Y; Morilla-Grasa A; Lopez R; Rabano G; Fernández N; Mayo-Iscar A
    Melanoma Res; 2002 Oct; 12(5):441-7. PubMed ID: 12394185
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immune Checkpoint Inhibitors in Uveal and Conjunctival Melanoma.
    Wierenga APA; Cao J; Luyten GPM; Jager MJ
    Int Ophthalmol Clin; 2019; 59(2):53-63. PubMed ID: 30908279
    [No Abstract]   [Full Text] [Related]  

  • 75. Tumour Expression of Histone Deacetylases in Uveal Melanoma.
    Levinzon L; Madigan M; Nguyen V; Hasic E; Conway M; Cherepanoff S
    Ocul Oncol Pathol; 2019 Apr; 5(3):153-161. PubMed ID: 31049320
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Development and use of monoclonal antibodies against an oncofetal protein associated with carcinogenesis and tumorigenesis.
    Runge SW; Larroya-Runge SN; Schumm DE; Webb TE
    Immunol Invest; 1991 Jun; 20(3):269-86. PubMed ID: 1874559
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antigens of human melanoma as defined by monoclonal antibodies. Second workshop on monoclonal antibodies to melanoma. National Institutes of Health, National Cancer Institute, Bethesda, Maryland, USA, April 26-27, 1982.
    Hybridoma; 1982; 1(4):379-482. PubMed ID: 6926854
    [No Abstract]   [Full Text] [Related]  

  • 78. Tumour-associated antigens in cystic melanomas.
    Jackson AM; Vose BM; Cochran AJ
    Eur J Cancer (1965); 1978 May; 14(5):543-7. PubMed ID: 648569
    [No Abstract]   [Full Text] [Related]  

  • 79. [Measurement of serum MP-A11 in patients with cancer of digestive organs].
    Morita M
    Nihon Shokakibyo Gakkai Zasshi; 1987 Apr; 84(4):941. PubMed ID: 3613233
    [No Abstract]   [Full Text] [Related]  

  • 80. Preparation and characterization of a mouse monoclonal antibody against a rat kidney papillary antigen.
    Hildebrand H; Falkenberg FW; Schwengberg S; Schlüter G; Bomhard E
    Toxicol In Vitro; 1993 Jul; 7(4):421-5. PubMed ID: 20732227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.